Florida tracks migrant health care costs
Fox News reporter Danamarie McNicholl has the latest on Florida's $566 million medical bill on 'The Evening Edit.'
Prenosis CEO: This AI tool lets doctors better understand your unique biology for sepsis detection
Prenosis co-founder and CEO Bobby Reddy Jr. discusses how artificial intelligence will change health care in treating sepsis on 'The Claman Countdown.'
Rotating shifts has a negative impact on sleep quality: Dr. Marty Makary
Fox News medical contributor Dr. Marty Makary weighs in on a new study that working irregular hours can harm your health during an appearance on ‘Varney & Co.’
Costco offers members access to Ozempic, Wegovy
Johns Hopkins professor of public health Dr. Marty Makary discusses Costco offering Ozempic and Wegovy to members and the use of these drugs.
Contrave mimics diet and exercise: George Hampton
Currax Pharmaceuticals President & CEO George Hampton breaks down the weight loss solution on 'The Claman Countdown.'
RBC analyst: Investors are more focused on the fundamentals of Tesla as opposed to anything going on personally with its CEO
RBC Capital global autos analyst Tom Narayan and Fox News medical contributor Dr. Marc Siegel discuss Elon Musk’s reported drug use on 'The Claman Countdown.'
Fed will be 'late to the game' in cutting rates: Mario Veneroso
Kingsview Asset Management partner Mario Veneroso and Strategic Wealth Partners CEO Mark Tepper discuss their market outlook ahead of the GDP read and February PCE, as well as healthcare and small-cap stocks.
Loneliness worse than smoking, alcoholism, obesity: Study suggests
Fox News medical contributor Dr. Marty Makary discusses a new study that suggests loneliness can lead to premature death on 'Varney & Co.'
New ‘exercise pill’ has ‘legitimate’ medical uses: Dr. Frank Contacessa
Custom Care medical internist Dr. Frank Contacessa joins ‘Varney & Co.’ to discuss a new pill that could allegedly replace the need to exercise.
Dr. Marty Makary: A lot of censored speech during the COVID-19 pandemic ended up being correct
Dr. Marty Makary discusses social media censorship during the coronavirus pandemic on 'The Evening Edit.'
Eli Lilly's campaign seeks to resolve weight-loss drug misconceptions
Eli Lilly is launching a campaign aimed at informing consumers about the seriousness of diabetes as a disease and the appropriate use of its weight-loss-related drugs.
Dr. Frank Contacessa on 'interesting' study of treating anxiety with single dose of LSD
Custom Care medical internist Dr. Frank Contacessa discusses Novo Nordisk's new weight loss pill and a study saying a single dose of LSD can help treat anxiety.
Why are doctors charging for administrative tasks?
Fox News medical contributor Dr. Marc Siegel reacts to doctors charging for medication refills and doctors' notes on 'The Bottom Line.'
Eye products sold at Walmart, CVS could pose infection risk
The Food and Drug Administration is warning consumers about eye products that are being recalled over concerns that they could pose a risk of infection.
Pharmacies scramble to serve sick customers as 'nation-state' blamed for ongoing cyberattack outage
Change Healthcare says a "cyber security issue" affecting operations at U.S. pharmacies nationwide is still ongoing Friday.
Popular weight loss drugs see sharp price increases
Custom Care medical internist Dr. Frank Contacessa discusses popular weight loss drugs and shares his perspective on COVID boosters.
Active investors could have a 'very good year,' says Craig Johnson
Piper Sandler managing director and chief market technician Craig Johnson discusses his market expectations and his outlook for the heath and banking sectors.
John Sculley: 'Tim Cook comparing Vision Pro to first iPhone is 100% correct'
Former Apple CEO John Sculley gives huge thumbs up to new technology and sees it as big disruptor on 'The Claman Countdown.'
Biogen drops controversial Alzheimer's drug, focuses on other treatments
Biogen will discontinue development of its controversial drug Aduhelm so it can shift efforts to other drugs, including Leqembi, which it developed with Eisai.
Weight loss medication shortage creates market for bogus drugs
World health officials are warnings that the shortage of diabetes and weight loss-related drugs, which are in high demand, are creating a rise in counterfeit versions.